189 related articles for article (PubMed ID: 11869573)
1. Interferon for acute hepatitis C.
Poynard T; Regimbeau C; Myers RP; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP
Cochrane Database Syst Rev; 2002; 2001(1):CD000369. PubMed ID: 11869573
[TBL] [Abstract][Full Text] [Related]
2. Interferon for interferon naive patients with chronic hepatitis C.
Myers RP; Regimbeau C; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP; Poynard T
Cochrane Database Syst Rev; 2002; 2002(2):CD000370. PubMed ID: 12076394
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for acute hepatitis C infection.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha for chronic hepatitis D.
Abbas Z; Khan MA; Salih M; Jafri W
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD006002. PubMed ID: 22161394
[TBL] [Abstract][Full Text] [Related]
5. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
6. Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.
Mellerup MT; Krogsgaard K; Mathurin P; Gluud C; Poynard T
Cochrane Database Syst Rev; 2002; (2):CD000345. PubMed ID: 12076393
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin with or without alpha interferon for chronic hepatitis C.
Kjaergard LL; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2002; (2):CD002234. PubMed ID: 12076442
[TBL] [Abstract][Full Text] [Related]
8. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
9. Interferon therapy for acute hepatitis C viral infection--a review by meta-analysis.
Quin JW
Aust N Z J Med; 1997 Oct; 27(5):611-7; discussion 617-8. PubMed ID: 9404604
[TBL] [Abstract][Full Text] [Related]
10. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
11. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials.
Carithers RL; Emerson SS
Hepatology; 1997 Sep; 26(3 Suppl 1):83S-88S. PubMed ID: 9305670
[TBL] [Abstract][Full Text] [Related]
12. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
13. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Myers RP; Poynard T
Cochrane Database Syst Rev; 2002; (4):CD003617. PubMed ID: 12519606
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.
Kjaergard LL; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2002; (1):CD002234. PubMed ID: 11869633
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.
Thévenot T; Regimbeau C; Ratziu V; Leroy V; Opolon P; Poynard T
J Viral Hepat; 2001 Jan; 8(1):48-62. PubMed ID: 11155152
[TBL] [Abstract][Full Text] [Related]
16. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
17. Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.
Mellerup MT; Krogsgaard K; Mathurin P; Gluud C; Poynard T
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD000345. PubMed ID: 16034852
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
[TBL] [Abstract][Full Text] [Related]
19. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
Kamal SM; Fouly AE; Kamel RR; Hockenjos B; Al Tawil A; Khalifa KE; He Q; Koziel MJ; El Naggar KM; Rasenack J; Afdhal NH
Gastroenterology; 2006 Mar; 130(3):632-8. PubMed ID: 16530503
[TBL] [Abstract][Full Text] [Related]
20. Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment.
Gürsoy M; Gür G; Arslan H; Ozdemir N; Boyacioglu S
J Viral Hepat; 2001 Jan; 8(1):70-7. PubMed ID: 11155154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
